Assoicated Medical Conditions for Multiple Sclerosis

The following is based on bacteria published studies. These are report on the averages of a group of patients; they do not apply to all patients and are not necessary predictive.

For some medical conditions there are hundreds of bacteria shifts reported, for others only a few. The Percentage is based on the least number. If there are matches 8 matches for a condition that has 10 known bacteria shifts, against a condition that has 50 bacteria shifts. It will be 8/10 or 80% and not 8/50= 16%. The count of possible bacteria is shown for reference.

Associations

Limited to conditions with 5 or more bacteria

Name Percent Est Matches Bacteria in From Bacteris in To
Allergies 22 % 11 50 100
Alzheimer's disease 46 % 23 50 100
Autism 31 % 31 110 100
Ulcerative colitis 25 % 25 108 100
Rosacea 40.9 % 9 22 100
Schizophrenia 30.1 % 28 93 100
Ankylosing spondylitis 35 % 35 520 100
Mood Disorders 50 % 3 6 100
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 32 % 32 134 100
High Blood Pressure 25.5 % 12 47 100
Psoriasis 34.8 % 16 46 100
Obesity 27.3 % 15 55 100
Obesity 18 % 18 104 100
Amyotrophic lateral sclerosis (ALS) Motor Neuron 23.3 % 10 43 100
Osteoporosis 27.3 % 6 22 100
neuropsychiatric disorders (PANDAS, PANS) 33.3 % 5 15 100
ME/CFS with IBS 26.3 % 5 19 100
ME/CFS without IBS 23.1 % 6 26 100
Multiple system atrophy (MSA) 38.1 % 8 21 100
Metabolic Syndrome 28.6 % 2 7 100
Systemic Lupus Erythematosus 27.3 % 18 66 100
Liver Cirrhosis 48 % 48 678 100
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 19.7 % 15 76 100
Parkinson's Disease 28.9 % 26 90 100
Chronic Kidney Disease 31.4 % 11 35 100
Insomnia 70 % 7 10 100
Depression 23.5 % 19 81 100
Irritable Bowel Syndrome 32.3 % 20 62 100
Chronic Urticaria (Hives) 47.8 % 11 23 100
IgA nephropathy (IgAN) 24.1 % 7 29 100
Hyperlipidemia (High Blood Fats) 36 % 9 25 100
hypertension (High Blood Pressure 50 % 3 6 100
hypercholesterolemia (High Cholesterol) 22.2 % 2 9 100
gallstone disease (gsd) 33.3 % 5 15 100
Graves' disease 25 % 2 8 100
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 29.2 % 7 24 100
Fibromyalgia 35.1 % 13 37 100
Functional constipation / chronic idiopathic constipation 39 % 16 41 100
Epilepsy 32 % 8 25 100
Cerebral Palsy 58.8 % 10 17 100
Inflammatory Bowel Disease 33.3 % 22 66 100
Type 1 Diabetes 30.8 % 16 52 100
cystic fibrosis 28.6 % 2 7 100
COVID-19 22.2 % 8 36 100
Carcinoma 31.4 % 16 51 100
Colorectal Cancer 24 % 24 296 100
Celiac Disease 19.4 % 13 67 100
Chronic Fatigue Syndrome 21.8 % 12 55 100
Crohn's Disease 36 % 36 141 100
Coronary artery disease 12.5 % 2 16 100
Barrett esophagus cancer 18.8 % 3 16 100
Generalized anxiety disorder 14.3 % 2 14 100
Bipolar Disorder 36.4 % 12 33 100
Asthma 37 % 10 27 100
Atherosclerosis 37 % 37 524 100
Acne 42.1 % 8 19 100
Stress / posttraumatic stress disorder 28.6 % 16 56 100
Small Intestinal Bacterial Overgrowth (SIBO) 25 % 4 16 100
Brain Trauma 36.4 % 8 22 100
Sjögren syndrome 29.3 % 12 41 100
Type 2 Diabetes 51 % 51 267 100
ADHD 38.3 % 18 47 100
Hashimoto's thyroiditis 35.7 % 5 14 100

(Legacy User)

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.